Interpreting Tracheal High-Flow Dynamics During Spontaneous Breathing Trials: Insights Beyond Inspiratory Effort
-
By
-
Li-Xia Xu
-
September 7, 2026
By
Li-Xia Xu
September 7, 2026
by Li-Xia Xu
September 7, 2026
September 9, 2026
Nearly half of hospitalized patients had detectable reactivation of at least one chronic virus
September 7, 2026
Nirmatrelvir–ritonavir for up to 25 days failed to improve cognitive, autonomic, or exercise symptoms compared with placebo in a phase 2 trial.
September 4, 2026